- Home
- SFST vs TRDA Comparison
SFST vs TRDA Comparison
Compare SFST & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFST
- TRDA
- Stock Information
- Founded
- SFST 1999
- TRDA 2016
- Country
- SFST United States
- TRDA United States
- Employees
- SFST N/A
- TRDA N/A
- Industry
- SFST Major Banks
- TRDA Biotechnology: Pharmaceutical Preparations
- Sector
- SFST Finance
- TRDA Health Care
- Exchange
- SFST Nasdaq
- TRDA Nasdaq
- Market Cap
- SFST 285.9M
- TRDA 301.0M
- IPO Year
- SFST 1999
- TRDA 2021
- Fundamental
- Price
- SFST $35.69
- TRDA $7.12
- Analyst Decision
- SFST Buy
- TRDA Strong Buy
- Analyst Count
- SFST 1
- TRDA 3
- Target Price
- SFST $43.00
- TRDA $25.67
- AVG Volume (30 Days)
- SFST 15.0K
- TRDA 126.5K
- Earning Date
- SFST 07-17-2025
- TRDA 08-12-2025
- Dividend Yield
- SFST N/A
- TRDA N/A
- EPS Growth
- SFST 37.29
- TRDA N/A
- EPS
- SFST 2.25
- TRDA 0.61
- Revenue
- SFST $97,501,000.00
- TRDA $172,220,000.00
- Revenue This Year
- SFST $4.07
- TRDA N/A
- Revenue Next Year
- SFST $8.99
- TRDA N/A
- P/E Ratio
- SFST $16.08
- TRDA $11.70
- Revenue Growth
- SFST 11.95
- TRDA 5.74
- 52 Week Low
- SFST $26.43
- TRDA $6.94
- 52 Week High
- SFST $45.91
- TRDA $21.79
- Technical
- Relative Strength Index (RSI)
- SFST 51.86
- TRDA 36.18
- Support Level
- SFST $34.80
- TRDA $6.94
- Resistance Level
- SFST $37.17
- TRDA $8.49
- Average True Range (ATR)
- SFST 0.89
- TRDA 0.42
- MACD
- SFST -0.07
- TRDA -0.07
- Stochastic Oscillator
- SFST 63.53
- TRDA 10.91
About SFST Southern First Bancshares Inc.
Southern First Bancshares Inc is a bank holding company. The company engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the FDIC), and providing commercial, consumer and mortgage loans to the general public of which a majority of the revenue is derived from the Commercial and Retail Banking segment which includes the provision of traditional deposit and lending products and services to its commercial and retail banking clients.
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.